DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 116 filers reported holding DICE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 2.21 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $15,027,626 | -5.7% | 323,453 | -41.9% | 0.02% | -11.8% |
Q1 2023 | $15,936,305 | -25.2% | 556,241 | -18.6% | 0.02% | -29.2% |
Q4 2022 | $21,307,541 | +10293.9% | 682,934 | +6271.8% | 0.02% | – |
Q1 2022 | $205,000 | -87.4% | 10,718 | -83.3% | 0.00% | -100.0% |
Q4 2021 | $1,624,000 | – | 64,146 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Northpond Ventures, LLC | 3,292,871 | $83,343,000 | 29.17% |
Sands Capital Ventures, LLC | 3,148,970 | $79,700,000 | 11.81% |
OUP Management Co., LLC | 536,693 | $13,584,000 | 6.12% |
New Leaf Venture Partners, L.L.C. | 556,693 | $14,090,000 | 5.10% |
Logos Global Management LP | 1,664,251 | $42,122,000 | 4.34% |
Asymmetry Capital Management, L.P. | 185,201 | $4,687,000 | 2.49% |
Deep Track Capital, LP | 1,341,004 | $33,941,000 | 2.40% |
RA Capital Management | 5,208,911 | $131,838,000 | 2.32% |
Soleus Capital Management, L.P. | 810,940 | $20,525,000 | 2.06% |
Miller Investment Management, LP | 180,901 | $4,579,000 | 0.66% |